AbL Diagnostics SA
PAR:ABLD
Cash Flow Statement
Cash Flow Statement
AbL Diagnostics SA
| Jun-2019 | Dec-2019 | Jun-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||
| Net Income |
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
1
|
1
|
0
|
0
|
0
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
2
|
2
|
(0)
|
(0)
|
0
|
|
| Change in Working Capital |
(0)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(3)
|
(2)
|
1
|
1
|
(0)
|
|
| Cash from Operating Activities |
(0)
N/A
|
(0)
+23%
|
0
N/A
|
(0)
N/A
|
(0)
+60%
|
(0)
-217%
|
(0)
+70%
|
1
N/A
|
1
+85%
|
1
-15%
|
0
-71%
|
|
| Investing Cash Flow | ||||||||||||
| Capital Expenditures |
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(1)
|
(1)
|
0
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
1
|
0
|
0
|
(0)
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(1)
-14 820%
|
(2)
-13%
|
(1)
+69%
|
(1)
-38%
|
0
N/A
|
|
| Financing Cash Flow | ||||||||||||
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
1
|
0
|
1
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
1
|
|
| Cash from Financing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
0
N/A
|
1
+270%
|
0
-91%
|
1
+783%
|
|
| Change in Cash | ||||||||||||
| Net Change in Cash |
(0)
N/A
|
(0)
+35%
|
0
N/A
|
0
+271%
|
0
+32%
|
(0)
N/A
|
(2)
-789%
|
(1)
+43%
|
1
N/A
|
0
-89%
|
1
+577%
|
|
| Free Cash Flow | ||||||||||||
| Free Cash Flow |
(0)
N/A
|
(0)
+23%
|
0
N/A
|
(0)
N/A
|
(0)
+60%
|
(0)
-217%
|
(2)
-951%
|
(2)
-1%
|
(0)
+99%
|
(0)
-114%
|
0
N/A
|
|